Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-05-11 | Dr. Cook earned a BA from Loyola University, M.Aud. from University of South Carolina, and PhD from Arizona State University in Hearing Science. Her experience is scientific and clinical; no mention of software or programming skills. |
| 2021-05-25 | Dr. Cook previously served as SVP and Head of Gene Therapy Strategy at PTC Therapeutics and was COO of Agilis Biotherapeutics. She earned a BA, M.Aud., and PhD in Hearing Science and has been Assistant Professor of Audiology and Director of the Hearing Aid Program at Mayo Clinic. |
| 2022-05-02 | Dr. Cook earned a BA from Loyola University in Maryland, M.Aud. from University of South Carolina, and PhD from Arizona State University in Hearing Science. |
| 2023-04-28 | Dr. Cook earned a BA from Loyola University in Maryland, M.Aud. from University of South Carolina, and PhD from Arizona State University in Hearing Science. She completed a clinical fellowship at Johns Hopkins School of Medicine in Baltimore, MD. Her extensive scientific, clinical and executive business experience strengthens the Board’s collective qualifications, skills and expertise. |
| 2024-05-13 | Dr. Cook earned a BA from Loyola University in Maryland, M.Aud. from University of South Carolina, and PhD from Arizona State University in Hearing Science. She completed a clinical fellowship at Johns Hopkins School of Medicine in Baltimore, MD. Her extensive scientific, clinical and executive business experience strengthens the Board’s collective qualifications, skills and expertise. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22